In patients with ST-segment elevation myocardial infarction (STEMI), early subcutaneous administration of zalunfiban significantly improved coronary artery patency and reduced…
Intracoronary infusion of Wharton’s jelly–derived mesenchymal stem cells after acute myocardial infarction (AMI) significantly reduced the risk of developing heart…
In a US community-based study of patients aged ≤65 years between 2003 and 2018, researchers identified 1,474 index myocardial infarction…
A Chinese nationwide case-crossover study revealed that lower temperatures were associated with higher risks of myocardial infarction (MI), and that…
A French multicenter, open label, randomized, noninferiority trial suggested that interruption of long-term beta-blocker treatment was not found to be…
A prospective Danish cohort study revealed that subclinical obstructive coronary atherosclerosis is associated with a more than 8-fold elevated risk…
A population-based, prospective cohort study in Iceland revealed that the long-term mortality risk of unrecognized myocardial infarction (UMI) can be…
This website uses cookies.